These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Validation of a [Al Al-Momani E; Israel I; Samnick S Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199 [TBL] [Abstract][Full Text] [Related]
4. Development of Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and pre-clinical evaluation of a new class of high-affinity Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991 [TBL] [Abstract][Full Text] [Related]
6. New aspects of molecular imaging in prostate cancer. Ceci F; Castellucci P; Cerci JJ; Fanti S Methods; 2017 Nov; 130():36-41. PubMed ID: 28711565 [TBL] [Abstract][Full Text] [Related]
7. One-Step Kuo HT; Lepage ML; Lin KS; Pan J; Zhang Z; Liu Z; Pryyma A; Zhang C; Merkens H; Roxin A; Perrin DM; Bénard F J Nucl Med; 2019 Aug; 60(8):1160-1166. PubMed ID: 30737299 [TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation and Pilot Clinical Study of Al Liu T; Liu C; Xu X; Liu F; Guo X; Li N; Wang X; Yang J; Yang X; Zhu H; Yang Z J Nucl Med; 2019 Sep; 60(9):1284-1292. PubMed ID: 30796170 [TBL] [Abstract][Full Text] [Related]
9. PET imaging in prostate cancer: focus on prostate-specific membrane antigen. Mease RC; Foss CA; Pomper MG Curr Top Med Chem; 2013; 13(8):951-62. PubMed ID: 23590171 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and preclinical evaluation of an Al Huang Y; Li H; Ye S; Tang G; Liang Y; Hu K Eur J Med Chem; 2021 Oct; 221():113502. PubMed ID: 33965863 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722 [TBL] [Abstract][Full Text] [Related]
12. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol. Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of peptide-based imaging agents [ Zhang-Yin J; Provost C; Cancel-Tassin G; Rusu T; Penent M; Radulescu C; Comperat E; Cussenot O; Montravers F; Renard-Penna R; Talbot JN; Prignon A Nucl Med Biol; 2020; 84-85():88-95. PubMed ID: 32251995 [TBL] [Abstract][Full Text] [Related]
14. Recent advancements in Piron S; Verhoeven J; Vanhove C; De Vos F Nucl Med Biol; 2022; 106-107():29-51. PubMed ID: 34998217 [TBL] [Abstract][Full Text] [Related]
15. Imaging of Prostate-Specific Membrane Antigen Using [ Rowe SP; Gorin MA; Pomper MG PET Clin; 2017 Jul; 12(3):289-296. PubMed ID: 28576167 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy. Arsenault F; Beauregard JM; Pouliot F Curr Opin Support Palliat Care; 2018 Sep; 12(3):359-365. PubMed ID: 29939893 [TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Characterization of an Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329 [TBL] [Abstract][Full Text] [Related]
18. Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications. Rowe SP; Gorin MA; Pomper MG Annu Rev Med; 2019 Jan; 70():461-477. PubMed ID: 30691373 [TBL] [Abstract][Full Text] [Related]
19. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]